Showing 701-710 of 974 results for "".
- Ophthotech Announces the Addition of Calvin W. Roberts, MD, to Its Board of Directorshttps://modernod.com/news/ophthotech-announces-the-addition-of-ophthalmic-industry-leader-calvin-w-roberts-md-to-its-board-of-directors/2476231/Ophthotech Corporation announced the election of Calvin (Cal) W. Roberts, MD, Senior Vice President and Chief Medical Officer, Eye Care at Bausch Health Companies, and Clinical Professor of Ophthalmology at Weill Medical College of Cornell University, to its Board of Directors, effective as of Ja
- Reay H. Brown, MD, Joins Sight Sciences as Chief Medical Officerhttps://modernod.com/news/reay-h-brown-md-joins-sight-sciences-as-chief-medical-officer/2479741/Sight Sciences announced that Reay H. Brown, MD, has joined the company as Chief Medical Officer (CMO). Dr. Brown is one of the most prolific inventors and innovators in the history of surgical glaucoma. He was the original inventor of trabecular microbypass stenting, which has served as t
- Thomas A. Finley, MD, Appointed Chairmen of Ocutrx International Medical Advisory Boardhttps://modernod.com/news/thomas-a-finley-md-appointed-chairmen-of-ocutrx-international-medical-advisory-board/2479996/Ocutrx Vision Technologies, a California-based augmented reality (AR) glasses developer announced that Thomas A. Finley, MD, will serve as the Chairman of the Ocutrx International Medical Advisory Board (IMAB). The board serves to advise Ocutrx in its development of augmented reality glasses for
- Eye Health America Appoints Cathleen McCabe, MD, as Chief Medical Officerhttps://modernod.com/news/eye-health-america-appoints-cathleen-mccabe-md-as-chief-medical-officer/2480162/Eye Health America (EHA) has appointed Cathleen McCabe, MD, as its chief medical officer. As the newest member of EHA’s executive leadership team, Dr. McCabe will be responsible for the development, implementation, and continuation of best practices across EHA’s group practices and ambulatory sur
- Thomas W. Samuelson, MD, Named 2018 ASCRS Presidenthttps://modernod.com/news/thomas-w-samuelson-md-named-2018-ascrs-president/2480251/Thomas W. Samuelson, MD, a world-renowned ophthalmologist who specializes in the medical and surgical treatment of glaucoma and disorders of the anterior segment, will assume his role as president of the American Society of Cataract and Refractive Surgery (ASCRS) in April 2018. He currently serve
- Abigail Markward Named Executive Director of ASOAhttps://modernod.com/news/abigail-markward-named-executive-director-of-asoa/2482399/The American Society of Ophthalmic Administrators (ASOA) has announced the appointment of Abigail Markward, MBA, as its new executive director, effective immediately. In addition to this new role, Ms. Markward will continue her responsibilities as executive director of the ASCRS Foundation, a pos
- Ocuphire Pharma Names Joseph Schachle as COOhttps://modernod.com/news/ocuphire-pharma-names-joseph-schachle-as-coo/2481981/Ocuphire Pharma announced the appointment of Joseph (Joe) K. Schachle, MBA, into the newly created role of Chief Operating Officer, effective immediately. Ocuphire is a clinical-stage company focused on developing and commercializing small-molecule therapies for the treatment of retinal and refra
- Sydnexis Appoints Nick Ruth Chief as Commercial Officerhttps://modernod.com/news/sydnexis-appoints-nick-ruth-chief-as-commercial-officer/2481799/Sydnexis has announced the appointment of industry veteran Nick Ruth, MBA, as its Chief Commercial Officer (COO). Mr. Ruth will lead Sydnexis’ commercial strategy and transition from a clinical based organization to both a clinical and commercial based organization. With
- Foundation Fighting Blindness Announces Leadership Changeshttps://modernod.com/news/foundation-fighting-blindness-announces-leadership-changes/2480924/The Foundation Fighting Blindness announced the promotions of Jason Menzo to chief executive officer of the Foundation, and Russell Kelley, PhD, MBA, to managing director of the Retinal Degeneration (RD) Fund, the venture arm of the Foundation, effective Ju
- Arnaud Lacoste Is Named Chief Scientific Officer of Aurion Biotechhttps://modernod.com/news/arnaud-lacoste-is-named-chief-scientific-officer-of-aurion-biotech/2479293/Arnaud Lacoste, MBA, PhD, has been named chief scientific officer of Aurion Biotech, whose mission is to cure blindness by developing a differentiated platform of advanced therapies. Arnaud will lead R&D teams based in Boston and Seattle. “Arnaud is a brilliant scientist, a strategic e